Aurora Cannabis ACB, a key player in the global medical marijuana market, stands at a strategic crossroads. Pablo…
ANALYST COVERAGE
8 analysts have expressed a variety of opinions on Aflac (NYSE:AFL) over the past quarter, offering a diverse…
4 analysts have expressed a variety of opinions on Ligand Pharmaceuticals (NASDAQ:LGND) over the past quarter, offering a…
Across the recent three months, 6 analysts have shared their insights on Safehold (NYSE:SAFE), expressing a variety of…
In the last three months, 11 analysts have published ratings on Blue Owl Cap (NYSE:OWL), offering a diverse…
Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Prudential Financial…
Throughout the last three months, 11 analysts have evaluated Crinetics Pharmaceuticals (NASDAQ:CRNX), offering a diverse set of opinions…
Analysts’ ratings for Twist Bioscience (NASDAQ:TWST) over the last quarter vary from bullish to bearish, as provided by…
Thermo Fisher Scientific (NYSE:TMO) has been analyzed by 10 analysts in the last three months, revealing a diverse…
Ratings for Array Technologies (NASDAQ:ARRY) were provided by 11 analysts in the past three months, showcasing a mix…
Across the recent three months, 5 analysts have shared their insights on Avantor (NYSE:AVTR), expressing a variety of…
Ratings for Stoke Therapeutics (NASDAQ:STOK) were provided by 5 analysts in the past three months, showcasing a mix…